Orgenesis Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was USD 36.03 million compared to USD 35.5 million a year ago. Revenue was USD 36.03 million compared to USD 35.5 million a year ago.

Net loss was USD 14.89 million compared to USD 18.05 million a year ago. Basic loss per share from continuing operations was USD 0.59 compared to USD 0.74 a year ago.